HLS @ 21 OCT 2021Text me if you have any questions/comments for me.
-----
HLS
- Previous analysis was done on 19 Sep (red arrow) -> recommended waiting for successful breakout of counter-trendline (purple dotted line) at around 4.90 levels before plotting entry if comfortable with strong overhead resistance zone
-
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.030 AUD
−645.80 M AUD
1.75 B AUD
570.59 M
About HEALIUS LIMITED
Sector
Industry
CEO
Paul Anderson
Website
Headquarters
Sydney
Founded
1994
ISIN
AU0000033359
FIGI
BBG000BBDQK8
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
HLS @ 19 OCT 2021 Text me if you have any questions/comments for me.
-----
HLS
- Previous analysis was done on 31 Aug (red arrow) -> recommended caution and suggested to wait for successful breakout of strong resistance zone at 5.15-5.35 levels
- Since then, the stock has created multiple LHs and is now trading at
HLS @ 31 Aug 2021HLS
- Previous analysis was done on 26 Aug -> suggested to wait for successful breakout of strong resistance
- Since then, the stock has retraced all the way down to test the mid-term support
- Today’s price action is first sign of a potential rebound -> but more positive indicators are required
- S
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of HLS is 1.390 AUD — it has increased by 1.83% in the past 24 hours. Watch HEALIUS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange HEALIUS LIMITED stocks are traded under the ticker HLS.
HLS stock has risen by 3.35% compared to the previous week, the month change is a 2.21% rise, over the last year HEALIUS LIMITED has showed a 8.59% increase.
We've gathered analysts' opinions on HEALIUS LIMITED future price: according to them, HLS price has a max estimate of 1.65 AUD and a min estimate of 0.94 AUD. Watch HLS chart and read a more detailed HEALIUS LIMITED stock forecast: see what analysts think of HEALIUS LIMITED and suggest that you do with its stocks.
HLS stock is 4.43% volatile and has beta coefficient of 1.08. Track HEALIUS LIMITED stock price on the chart and check out the list of the most volatile stocks — is HEALIUS LIMITED there?
Today HEALIUS LIMITED has the market capitalization of 1.01 B, it has decreased by −2.14% over the last week.
Yes, you can track HEALIUS LIMITED financials in yearly and quarterly reports right on TradingView.
HEALIUS LIMITED is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
HLS earnings for the last half-year are −0.028 AUD per share, whereas the estimation was −0.013 AUD, resulting in a −115.38% surprise. The estimated earnings for the next half-year are 0.0078 AUD per share. See more details about HEALIUS LIMITED earnings.
HEALIUS LIMITED revenue for the last half-year amounts to 933.90 M AUD, despite the estimated figure of 913.10 M AUD. In the next half-year revenue is expected to reach 725.12 M AUD.
HLS net income for the last half-year is −12.80 M AUD, while the previous report showed −10.00 M AUD of net income which accounts for −28.00% change. Track more HEALIUS LIMITED financial stats to get the full picture.
As of Apr 27, 2025, the company has 10.5 K employees. See our rating of the largest employees — is HEALIUS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEALIUS LIMITED EBITDA is 289.80 M AUD, and current EBITDA margin is 19.85%. See more stats in HEALIUS LIMITED financial statements.
Like other stocks, HLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEALIUS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEALIUS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEALIUS LIMITED stock shows the sell signal. See more of HEALIUS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.